FDA approves Teva Pharmaceuticals’ CU method The U.S. Food and Drug Administration (FDA) approved a content uniformity (CU) method from Teva Pharmaceuticals that uses the Agilent TRS100 Raman quantitative pharmaceutical analysis system.Read More
Researchers unlock the secrets of HIV protein Researchers from the Salk Institute and Rutgers University have determined the molecular structure of HIV Pol, a protein that plays a key role in the late stages of HIV replication.Read More
Mini kidneys reveal secrets of tuberous sclerosis complex Researchers from Ottawa, Ontario have discovered which cells cause tumors in patients with tuberous sclerosis complex by creating genetically engineered kidney organoids, or “mini kidneys” grown from human tissue.Read More
Researchers find how EGFR sends signals into cells, could help cancer drug design Chemists at the Massachusetts Institute of Technology have revealed how the epidermal growth factor receptor (EGFR) changes its shape when it binds to its target and how those changes trigger cells to grow and proliferate. Their insights into EGFR could help researchers design new cancer drugs that target this protein.Read More
NIH study shows how immune response to COVID-19 damages the brain A National Institutes of Health (NIH) study, which examined brain changes in nine people who died suddenly after contracting COVID-19, found that antibodies are involved in the attack on cells lining the brain's blood vessels, leading to inflammation and damage.Read More
Ga. researchers combine DNA barcoding, target sequencing Researchers in Georgia have developed a system to make preclinical nanoparticle studies more predictive that combines DNA barcoding with a multiomic nanoparticle delivery system called single-cell nanoparticle targeting-sequencing.Read More